PDS Biotechnology

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PDSB and other ETFs, options, and stocks.

About PDSB

PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. 

CEO
Frank K. Bedu-Addo
CEOFrank K. Bedu-Addo
Employees
22
Employees22
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
2005
Founded2005
Employees
22
Employees22

PDSB Key Statistics

Market cap
84.52M
Market cap84.52M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
130.48K
Average volume130.48K
High today
$3.25
High today$3.25
Low today
$2.97
Low today$2.97
Open price
$3.05
Open price$3.05
Volume
93.93K
Volume93.93K
52 Week high
$14.82
52 Week high$14.82
52 Week low
$2.91
52 Week low$2.91

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

PDSB Earnings

-$0.32
-$0.21
-$0.11
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, Pre-Market
ActualExpected Nov 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.